Mobilization and transplantation of Philadelphia chromosome-negative peripheral blood progenitor cells in patients with CML

British Journal of Haematology

Volumn 103, Issue 1, 1998, Pages 227-234

  Waller, Cornelius F ^a   Heinzinger, Monika ^a   Rosenstiel, Antonia ^a   Lange, Winand ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

CML; G CSF; IL 3; PBPC autologous transplantation

Indexed keywords

CYTARABINE; ETOPOSIDE; IDARUBICIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 2;

ADULT; APHERESIS; ARTICLE; AUTOTRANSPLANTATION; CELL TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CYTOGENETICS; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD COMPONENT REMOVAL; CHRONIC DISEASE; CYTOKINES; DISEASE-FREE SURVIVAL; FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKAPHERESIS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; PHILADELPHIA CHROMOSOME;

EID: 0031713559     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00964.x     Document Type: Article

References (40)

1. Allan, N.C., Richards, S.M. & Shepherd, P.C. (1995) UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult Leukaemia. Lancet, 345, 1392-1397.
2. Bartram, C.R., de Klein, A., Hagemeijer, A., van Agthoven, T., Geurts van Fessel, A., Bootsma, D., Grosveld, G., Ferguson-Smith, M.A., Davies, T., Stone, M., Heisterkamp, N., Stephenson, J.R. & Groffen, J. (1983) Translocation of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature, 306, 277-280.
3. Bhatia, R., Verfaillie, C.M., Miller, J.S. & McGlave, P.B. (1997) Autologous transplantation therapy for chronic myelogenous leukemia. Blood, 89, 2623-2634.
4. Boque, C., Petit, J., Sarra, J., Cancelas, J.A., Munoz, J., Espanol, J.I., de la Banda, E., Aventin, A., Berlanga, J., Ferra, C., Amill, B., Torrico, C., Azqueta, C., Llucia, M., Garcia, J. & Granena, A. (1996) Mobilization of peripheral stem cells with intensive chemotherapy (ICE regimen) and G-CSF in chronic myeloid leukemia. Bone Marrow Transplantation, 18, 879-884.
5. Carella, A.M., Chimirri, F., Podesta, M., Pitto, A., Piaggio, G., Dejana, A., Lerma, E., Pollicardo, N., Vassallo, F., Soracco, M., Benvenuto, F., Valbonesi, M., Carlier, P., Vimercati, R., Prencipe, E., Gatti, A.M., Ferrara, R.A., Incagliato, M., Florio, G. & Frassoni, F. (1996) High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia. Bone Marrow Transplantation, 17, 201-205.
6. Carella, A.M., Cunningham, I., Lerma, E., Dejana, A., Benvenuto, F., Podesta, M., Celesti, L., Chimirri, F., Abote, M., Vassallo, F., Figari, O., Parodi, C., Sessarego, M., Valbonesi, M., Carlier, P., Prencipe, E., Gatti, A.M., van den Berg, D., Hoffman, R. & Frassoni, F. (1997) Mobilization and transplantation of Philadelphia-negative peripheral-blood progenitor cells early in chronic myelogenous leukemia. Journal of Clinical Oncology, 15, 1575-1582.
7. Carella, A.M., Gaozza, E., Raffo, M.R., Carlier, P., Frassoni, F., Valbonesi, M., Lercari, G., Sessarego, M., Defferrari, R., Guerrasio, A., Saglio, G., Canepa, L., Gaetani, G.F. & Occhini, D. (1991) Therapy of acute phase chronic myelogenous leukemia with intensive chemotherapy, blood cell autotransplant and cyclosporine A. Leukemia, 5, 517-521.
8. Carella, A.M., Lerma, E., Celesti, L., Dejana, A., Panagiotis, Z., Corsetti, M.T. & Frassoni, F. (1998) Effective mobilization of Philadelphia-chromosome-negative cells in chronic myelogenous leukaemia patients using a less intensive regimen. British Journal of Haematology, 100, 445-448.
9. Daley, G.Q., Van Etten, R.A. & Baltimore, D. (1990) Induction of chronic myelogenous leukemia in mice by the P210 bcr/abl gene of the Philadelphia chromosome. Science, 247, 824-830.
10. + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood, 83, 3068-3076.
11. D'Hondt, V., Guillaume, T., Humblet, Y. Doyen, C., Chatelain, B., Feyens, A.M., Staquet, P., Osselaer, J.C., Mull, B. & Symann, M. (1994) Tolerance of sequential or simultaneous administration of IL-3 and G-CSF in improving peripheral blood stem cells harvesting following multi-agent chemotherapy: a pilot study. Bone Marrow Transplantation, 13, 261-264.
12. Elefanty, A.G., Hariharan, I.K. & Cory, S. (1990) bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice. EMBO Journal, 9, 1069-1078.
13. Gale, R.P., Grosveld, G., Canaani, E. & Goldman, J.M. (1993) Chronic myelogenous leukemia: biology and therapy. Leukemia, 7, 653-658.
14. Guilhot, G., Chastang, C., Michallet, M., Guerci, A., Harousseau, J.L., Maloisel, F., Bouabdallah, R., Guyotat, D., Cheron, N., Nicolini, F., Abgrall, J.F. & Tanzer, J. (1997) Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group. New England Journal of Medicine, 337, 223-229.
15. Hehlmann, R., Heimpel, H., Hasford, J., Kolb, H.J., Pralle, H., Hossfeld, D.K., Queisser, W., Loffler, H., Heinze, B., Georgii, A., Von Wussow, P., Bartram, C., Grisßhammer, M., Bergmann, L., Essers, U., Falge, C., Hochhaus, A., Queisser, U., Sick, C., Meyer, P., Schmitz, N., Verpoort, K., Eimermacher, H., Walther, F., Westerhausen, M., Kleeberg, U.R., Heilein, A., Käbisch, A., Barz, C., Zimmermann, R., Meuret, G., Tichelli, A., Berdel, W.E., Kanz, L., Anger, B., Tigges, F.J., Schmid, L., Brockhaus, W., Zankovich, R., Schäfer, U., Weißenfels, I., Mainzer, K., Tobler, A., Perker, M., Hohnioser, J., Messener, D., Thiele, J., Buhr, T., Ansari, H. and the German CML Study Group (1993) Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group. Blood, 82, 398-407.
16. Heinzinger, M., Waller, C.F., Rosenstiel, A., Scheid, S., Burger, K.J. & Lange, W. (1998) Quality of IL-3 and G-CSF-mobilized peripheral blood stem cells in patients with early chronic phase CML. Leukemia, 12, 333-339.
17. Hoyle, C., Gray, R. & Goldman, J. (1994) Autografting for patients with CML in chronic phase: an update. Hammersmith BMT Team. LRF Centre for Adult Leukaemia. British Journal of Haematology, 86, 76-81.
18. Huhn, R.D., Yurkow, E.J., Tushinski, R., Clarke, L., Sturgill, M.G., Hoffman, R., Sheay, W., Cody, R., Phillip, C., Resta, D. & George, M. (1996) Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers. Experimental Hematology, 24, 839-847.
19. Johnson, R.J., Owen, R.G., Child, J.A., Morgan, G.J., Barnard, D.L., Dickinson, H., Ricketts, S., Rawstron, A., Evans, P., Woodhead, V., Major, K., Robinson, F. & Smith, G.M. (1996) Mobilization of Philadelphia-negative peripheral blood mononucleur cells in chronic myeloid leukaemia using hydroxyurea and G-CSF (filgrastim). British Journal of Haematology, 93, 863-868.
20. Johnson, R.J. & Smith, G.M. (1997) Mobilisation and reinfusion of Philadelphia negative peripheral blood mononuclear cells in chronic myeloid leukaemia with hydroxyurea and G-CSF. Leukemia and Lymphoma, 27, 401-415.
21. Kantarjian, H.M., Talpaz, M., Hester, J., Feldman, E., Korbling, M., Liang, J., Rios, M.B., Smith, T.L., Calvert, L. & Deisseroth, A.B. (1995) Collection of peripheral-blood diploid cells from chronic myelogenous leukemia patients early in the recovery phase from myelosuppression induced by intensive-dose chemotherapy. Journal of Clinical Oncology, 13, 553-559.
22. Khouri, I.F., Kantarjian, H.M., Talpaz, M., Giralt, S., Rios, M.O., Hester, J.P., Champlin, R.E. & Deisseroth, A.B. (1996) Results with high-dose chemotherapy and unpurged autologous stem cell transplantation in 73 patients with chronic myelogenous leukemia: the MD Anderson experience. Bone Marrow Transplantation, 17, 775-779.
23. Koeffler, H.P. & Golde, D.W. (1991) Chronic myelogenous leukemia: new concepts. New England Journal of Medicine, 304, 1201-1209.
24. Konopka, J.B. & Witte, O.N. (1985) Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered ahl gene products. Molecular and Cellular Biology, 5, 3116-3123.
25. Maurer, J., Kinzel, H., Nentwig, T. & Thiel, R. (1990) Molecular diagnosis of the Philadelphia chromosome in chronic myelogenous and acute lymphoblastic leukemia by PCR. Disease Markers, 8, 211.
26. McGlave, P., Bartsch, G., Anasetti, C., Ash, R., Beatty, P., Gajewski, J. & Kernan, N.A. (1993) Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: inital experience of the National Marrow Donor Program. Blood, 81, 543-550.
27. McGlave, P.B., De Fabritiis, P., Deisseroth, A., Goldman, J., Barnett, M., Reiffers, J., Simonsson, B., Carella, A. & Aeppli, D. (1994) Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups. Lancet, 343, 1486-1488.
28. Mehta, J., Mijovic, A., Powles, R., Pagliuca, A., Singhal, S., Czepulkowski, B., Swansbury, G.J., Treleaven, J. & Mufti, G.J. (1996) Myelosuppressive chemotherapy to mobilize normal stem cells in chronic myeloid leukemia. Bone Marrow Transplantation, 17, 25-29.
29. Pettengell, R. & Testa, N.G. (1995) Biology of blood progenitor cells used in transplantation. International Journal of Hematology, 61, 1-15.
30. Podesta, M., Piaggio, G., Frassoni, F., Sesserego, M., Benvenuto, F., Figari, O., Pitto, A., Vassallo, F., Soracco, M., Pollicardo, M., Pungolino, E., Gatti, A., Prencipe, E. & Carella, A.M. (1995) Very primitive hemopoietic cells (LTC-IC) are present in Philadelphia negative cytaphereses collected during early recovery after chemotherapy for chronic myeloid leukemia (CML). Bone Marrow Transplantation, 16, 549-555.
31. Reiffers, J., Mahon, F.X., Boiron, J.M., Faberes, C., Marit, G., Cony-Makhoul, P. & Broustet, A. (1996) Autografting in chronic myeloid leukemia: an overview. Leukemia, 10, 385-388.
32. Rosenfeld, C.S., Bolwell, B., LeFever, A., Taylor, R., List, A., Fay, J., Collins, R., Andrews, F., Pallansch, P., Schuster, M.W., Resta, D., Levitt, D. & Nemunaitis, J. (1996) Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSF. Bone Marrow Transplantation, 17, 179-183.
33. Ross, D.W., Brunning, R.D., Kantarjian, H.M., Koeffler, H.P. & Ozer, H. (1993) A proposed staging system for chronic myeloid leukemia. Cancer, 71, 3788-3791.
34. Shtivelman, E., Lifshitz, B., Gale, R.P. & Canaani, E. (1985) Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature, 315, 550-554.
35. The Chronic Myeloid Leukemia Trialists' Collaborative Group (1997) Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials. Journal of the National Cancer Institute, 89, 1616-1620.
36. The Italian Cooperative Study Group on chronic myeloid leukemia (1994) Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. New England Journal of Medicine, 330, 820-825.
37. To, L.B., Haylock, D.N., Simmons, P.J. & Juttner, C.A. (1997) The biology and clinical uses of blood stem cells. Blood, 89, 2233-2258.
38. Torlakovic, E., Litz, C.E., McClure, J.S. & Brunning, R.D. (1994) Direct detection of the Philadelphia chromosome in CD20-positive lymphocytes in chronic myeloid leukemia by tri-color immunophenotyping/FISH. Leukemia, 8, 1940-1943.
39. Verfaillie, C.M., Bhatia, R., Miller, W., Mortari, F., Roy, V., Burger, S., McCullough, J., Stieglbauer, K., Dewald, G., Heimfeld, S., Miller, J.S. & McGlave, P.B. (1996) BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients. Blood, 87, 4770-4779.
40. Waller, C.F., Bertz, H., Wenger, M.K., Fetscher, S., Hardung, M., Engelhardt, M., Behringer, D., Lange, W., Mertelsmann, R. & Finke, J. (1996) Mobilization of peripheral blood progenitor cells for allogeneic transplantation: efficacy and toxicity of a high-dose rhG-CSF regimen. Bone Marrow Transplantation, 18, 279-283.